Compare NMTC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMTC | MYO |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.6M | 36.9M |
| IPO Year | 2010 | 2017 |
| Metric | NMTC | MYO |
|---|---|---|
| Price | $0.78 | $0.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $1.98 | ★ $7.67 |
| AVG Volume (30 Days) | 221.2K | ★ 416.3K |
| Earning Date | 01-01-0001 | 06-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.43 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $9,097,692.00 | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $15.92 |
| Revenue Next Year | $31.17 | $21.49 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 163.47 | ★ 40814.79 |
| 52 Week Low | $0.40 | $0.64 |
| 52 Week High | $1.15 | $5.62 |
| Indicator | NMTC | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 39.32 |
| Support Level | $0.69 | $0.68 |
| Resistance Level | $0.89 | $1.03 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 53.58 | 23.57 |
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).